Abilify Maintena, a new once-monthly injection of Abilify (aripiprazole) was approved by the FDA last month for the treatment of schizophrenia, and is now available from some providers. It is the first treatment option of its kind to offer a monthly injection, and although it will only be administered by your doctor or other healthcare professional, you may still find it more convenient than taking a daily pill for maintaining treatment and preventing relapse. It is recommended that if you haven’t already taken Abilify, you start with an oral dose to establish that you won’t have any negative reactions before trying the injection.
Abilify Maintena probably won’t be an inexpensive option, but it’s possible that it won’t cost you much more per month than the Abilify tablets, which can run close to $700 without insurance. However, in some cases you can split those Abilify tablets to reduce your costs, which won’t be possible with the injection, and insurance plans may be less likely to cover a newly-introduced expensive brand-name drug.
If you think Abilify Maintena might be a good choice for you, talk to your doctor and ask them to take a look at the Abilify Maintena Access Program. Your doctor will need to help you enroll, but you can get reimbursement support and help with insurance coverage through the program. You can find more information and the enrollment form here.